These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10160088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE, Gurwitz JH, Fish LS.
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists.
    Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ.
    Am J Gastroenterol; 2001 Mar; 96(3):673-6. PubMed ID: 11280532
    [Abstract] [Full Text] [Related]

  • 6. Nonprescription H2-receptor antagonists.
    Marsh TD.
    J Am Pharm Assoc (Wash); 1997 Mar; NS37(5):552-6. PubMed ID: 9479407
    [Abstract] [Full Text] [Related]

  • 7. Consumer usage patterns of nonprescription histamine2-receptor antagonists.
    Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S.
    Am J Gastroenterol; 2004 Apr; 99(4):606-10. PubMed ID: 15089889
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
    Shih YC, Prasad M, Luce BR.
    Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413
    [Abstract] [Full Text] [Related]

  • 10. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D, Houle JM, Pierce CH.
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [Abstract] [Full Text] [Related]

  • 11. Cost impact of switching histamine(2)-receptor antagonists to nonprescription status.
    Furler MD, Rolnick MS, Lawday KS, Mak MW, Einarson TR.
    Ann Pharmacother; 2002 Mar; 36(7-8):1135-41. PubMed ID: 12086543
    [Abstract] [Full Text] [Related]

  • 12. General practitioners' views on the over-the-counter availability of H2-antagonists.
    Erwin J, Britten N, Jones R.
    Br J Gen Pract; 1997 Feb; 47(415):99-102. PubMed ID: 9101694
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.
    Goulston KJ, Dent OF, Mant A, Logan J, Ngu M.
    Med J Aust; 1991 Jul 01; 155(1):20-6. PubMed ID: 1676825
    [Abstract] [Full Text] [Related]

  • 15. The cost-effectiveness of maintenance therapy for duodenal ulceration with an H2-antagonist.
    Fox N, Morton RE, Jacobs J.
    Aliment Pharmacol Ther; 1988 Aug 01; 2(4):297-309. PubMed ID: 2908756
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness and cost-utility of long-term management strategies for heartburn.
    Goeree R, O'Brien BJ, Blackhouse G, Marshall J, Briggs A, Lad R.
    Value Health; 2002 Aug 01; 5(4):312-28. PubMed ID: 12102694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn.
    Ciociola AA, Sirgo MA, Pappa KA, McGuire JA, Fung K.
    Am J Ther; 2001 Aug 01; 8(6):387-98. PubMed ID: 11704777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.